Ethyl 4-chlorothieno[2,3-b]pyridine-5-carboxylate, 95.0%, 5g

Cacothéline, >=95%, pa, 1 g, emballage en verre

h-arg(pbf)-oh, 95.0%, 100g

3-Amino-6-chloropyridine-2-carboxamide, 97.0%, 5g

5-(Piperidin-4-yl)-2-(trifluoromethyl)pyridine hydrochloride, 97%, 5g

3-Methylquinoxaline-5-carboxylic acid, 98.0%, 1g

(2E)-3-(4-chlorophenyl)-1-(2,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

Tri-Tert-Butyl 2,4-Dioxo-1,3,8-Triazaspiro[4.5]Decane-1,3,8-Tricarboxylate, 98%, 500mg

1,4-Cyclohexadiene ~0.1% hydroquinone as stabilizer, 25g

5-Phenoxymethyl-4-phenyl-4H-[1,2,4]triazole-3-thiol, 5g

Octadecanedioic acid mono-tert-butyl ester, 95.0%, 10g

2-(2-Methyl-1,3-dioxolan-2-yl)ethanamine, 95.0%, 10g

3-(Prop-2-yn-1-yloxy)aniline hydrochloride, 97%, 250mg